Chemodex

Deltamethrin

CHF 84.00
In stock
CDX-D0619-M250250 mgCHF 84.00
More Information
Product Details
Product Type Chemical
Properties
Formula

C22H19Br2NO3

MW 505.2
CAS 52918-63-5
RTECS GZ1233000
Source/Host Chemicals Synthetic.
Purity Chemicals ≥97% (HPLC)
Appearance White to light yellow powder.
Solubility Soluble in DMSO (15 mg/ml) or ethanol (1 mg/ml). Insoluble in water.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key OWZREIFADZCYQD-DXCJPMOASA-N
Smiles O=C(O[C@H](C#N)C1=CC=CC(OC2=CC=CC=C2)=C1)[C@H]3C(C)(C)[C@H]3/C=C(Br)/Br
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at RT.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Deltamethrin belongs to the class of synthetic pyrethroids, which are being widely used as insecticides. Deltamethrin acts on voltage-gated sodium channels (VGSCs) and voltage-gated calcium channels (VGCCs) that are the primary targets of these chemicals for toxicity to insects. Deltamethrin can increase neurotransmitter release which is associated with elevated levels of intrasynaptosomal free Ca2+ and protein phosphorylation activities. It acts as a potent inhibitor of calcineurin (protein phosphatase 2B), which results in cellular hyperexcitability by causing non-mutated calcium channels to remain open for an extended period of time allowing an abundance of Ca2+ to enter the cell. It also modulates sodium channels in the nerve cell membrane. It keeps the Na+ channels in an open state for a long time resulting to hyperactivity of the nervous system in mammals and insects. This compound can be used as a reference compound for analytical studies.

Product References

(1) K. Chinn & T. Narahashi; J. Physiol. 380, 191 (1986) | (2) E. Enan & F. Matsumura; Biochem. Pharmacol. 43, 1777 (1992) | (3) T. Narahashi; Trends Pharmacol. Sci. 13, 236 (1992) | (4) E. Enan & F. Matsumura; Biochem. Pharmacol. 45, 703 (1993) | (5) S.B. Symington & J.M. Clark; Pest. Biochem. Physiol. 82, 1 (2005) | (6) J.M. Clark & S.B. Symington; Invert. Neurosci. 7, 3 (2007) | (7) R. Zeng, et al.; Pestic. Biochem. Physiol. 138, 84 (2017) | (8) S.N. Bothe & A. Lampert; Toxicol. Appl. Pharmacol. 428, 115676 (2021)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.